Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Prostatic Neoplasms 12Urinary Bladder Neoplasms 3Wilms Tumor 2Sarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Melanoma 1Kidney Neoplasms 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Interventions

X-Rays 6Phantoms, Imaging 6Filgrastim 6Cyclophosphamide 6Carboplatin 6Specimen Handling 5Magnetic Resonance Spectroscopy 5Ifosfamide 5Temozolomide 4Nuclear Medicine Department, Hospital 4Gemcitabine 4Etoposide 4Granulocyte Colony-Stimulating Factor 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ixabepilone 2ivosidenib 2etoposide phosphate 2ensartinib 2cabozantinib 2belinostat 2Vincristine 2Vemurafenib 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Osteosarcoma × Radiotherapy, Conformal × Genitourinary × Clear all
NCT00550654 2017-01-13

Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
DermatologicGenitourinaryGynecologicSarcoma

Carcinoma, Renal Cell, Chondrosarcoma, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡